PGEN.NASDAQPrecigen, INC

Form 4: Precigen Director Nancy Agee Acquires Shares and Stock Units in Lieu of Retainer

Sentiment:

SEC Form 4 Filing


Director Nancy Agee acquired shares and restricted stock units of Precigen, Inc. on March 13, 2025, in lieu of an annual retainer.

Summary

  • On March 13, 2025, Nancy H. Agee, a director of Precigen, Inc., acquired 32,471 shares of common stock at $1.74 per share in lieu of an annual retainer of $56,500.
  • Agee also acquired 71,839 restricted stock units (RSUs), each representing a contingent right to receive one share of Precigen common stock, which vest in full on March 13, 2026.
  • Additionally, Agee acquired an option to purchase 83,517 shares of common stock at an exercise price of $1.74, expiring on March 13, 2035.
  • Following these transactions, Agee directly owns 50,076 shares of Precigen common stock and 71,839 RSUs, as well as the option to purchase 83,517 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The director's acquisition of shares and RSUs could be seen as a positive sign, but it's also part of their compensation.

Positives

  • The acquisition of shares and RSUs by a director signals confidence in the company's future prospects.
  • The acceptance of shares in lieu of cash retainer preserves cash for the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the trading activities of company directors and officers, which can be indicative of their confidence in the company's prospects.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates

DateDescription
03/13/2025Date of transaction: Acquisition of common stock, RSUs, and stock options.
03/13/2026Vesting date for the 71,839 Restricted Stock Units (RSUs).
03/13/2035Expiration date for the option to purchase 83,517 shares of common stock.
03/17/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.